Charles Piller’s Doctored reveals a crisis of integrity at the
heart of Alzheimer’s research, exposing systemic fraud, institutional negligence, and corporate influence that have derailed progress toward effective treatments. The book, based on years of investigative reporting, traces how falsified data, manipulated research, and conflicts of interest corrupted the field, leaving millions of patients and families struggling for answers.
Charles Piller is an investigative journalist for Science magazine and his work has appeared in the Los Angeles Times, The New York Times, The Sacramento Bee, and more. Piller has been honored with many national journalism awards, and is the author of Gene Wars, The Fail-Safe Society, and Doctored. He has reported on public health, biological warfare, infectious disease outbreaks, and other topics from the United States, Africa, Asia, Europe, and
Central America. Follow him on X @CPiller / charlespiller.com.
The amyloid hypothesis of Alzheimer's disease is thedominant way of looking at the ailment and its origins. Hundreds of respected Alzheimer’s research papers are based on false data proving this hypothesis, receiving billions in research and development funds.
Manipulating microscopic brain tissue images and Westernblot images significantly impacts data interpretation and scientific acceptance. Such alterations can misrepresent results, erode scientific integrity, lead to flawed conclusions, and create irreproducible findings. These manipulations constitute ethical violations and scientific misconduct.
Universities face a significant challenge in addressingscientific misconduct among faculty due to inherent conflicts of interest. The need to maintain research integrity often clashes with protecting institutional reputation, securing funding, and retaining prominent researchers. This conflict can lead to inadequate oversight and investigation of potential misconduct.
New ideas about the cause of Alzheimer’s are on the horizon,including the possibility of latent infections as a factor in Alzheimer's, such as herpes virus. Clinical trials are in progress to try to treat herpes virus that may be latent in the brain. Another possible factor is inflammation. GLP-1 inhibitors are being studied to delay cognitive decline.
Controlling blood pressure and cholesterol levels, and havinga healthy lifestyle are beneficial to stave off Alzheimer’s disease.